These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22057179)

  • 21. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
    Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
    Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of repetitive stress during the acute phase of Trypanosoma cruzi infection on chronic Chagas' disease in rats.
    Caetano LC; Brazão V; Filipin Mdel V; Santello FH; Caetano LN; Toldo MP; Caldeira JC; do Prado JC
    Stress; 2009 Mar; 12(2):144-51. PubMed ID: 18850489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi.
    Bombeiro AL; D'Império Lima MR; Chadi G; Alvarez JM
    Neuroimmunomodulation; 2010; 17(2):67-78. PubMed ID: 19923851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of melatonin therapy and orchiectomy on T cell subsets in male Wistar rats infected with Trypanosoma cruzi.
    Santello FH; Del Vecchio Filipin M; Caetano LC; Brazão V; Caetano LN; Dos Santos CD; Alonso Toldo MP; do Prado JC
    J Pineal Res; 2009 Oct; 47(3):271-6. PubMed ID: 19709396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.
    Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S
    Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormones therapy in immune response against Trypanosoma cruzi.
    Frare EO; Santello FH; Caetano LC; Caldeira JC; Toldo MP; Prado JC
    Res Vet Sci; 2010 Apr; 88(2):273-8. PubMed ID: 19883928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of melatonin on thymic and oxidative stress dysfunctions during Trypanosoma cruzi infection.
    Brazão V; Colato RP; Santello FH; Vale GTD; Gonzaga NA; Tirapelli CR; Prado JCD
    J Pineal Res; 2018 Oct; 65(3):e12510. PubMed ID: 29781553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
    Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC
    Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi.
    Oliveira LG; Kuehn CC; Santos CD; Toldo MP; do Prado JC
    Parasite Immunol; 2010 Apr; 32(4):245-51. PubMed ID: 20398224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
    Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
    Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
    Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
    Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease.
    Maçao LB; Wilhelm Filho D; Pedrosa RC; Pereira A; Backes P; Torres MA; Fröde TS
    Int J Cardiol; 2007 Dec; 123(1):43-9. PubMed ID: 17328977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.